196 related articles for article (PubMed ID: 7957619)
1. Effect of BQ-123 and Ro 47-0203 (bosentan) on endothelin-induced vasoconstriction in the rat skin.
Lawrence E; Brain SD
Eur J Pharmacol; 1994 Jul; 260(1):103-6. PubMed ID: 7957619
[TBL] [Abstract][Full Text] [Related]
2. Endothelin B receptor-mediated vasoconstriction induced by endothelin A receptor antagonist.
Zhang Y; Oliver JR; Horowitz JD
Cardiovasc Res; 1998 Sep; 39(3):665-73. PubMed ID: 9861310
[TBL] [Abstract][Full Text] [Related]
3. Evidence for ETA and ETB receptors in rat skin and an investigation of their function in the cutaneous microvasculature.
Lawrence E; Siney L; Wilsoncroft P; Knock GA; Terenghi G; Polak JM; Brain SD
Br J Pharmacol; 1995 Jul; 115(5):840-4. PubMed ID: 8548185
[TBL] [Abstract][Full Text] [Related]
4. Articular nociception induced by endothelin-1, carrageenan and LPS in naive and previously inflamed knee-joints in the rat: inhibition by endothelin receptor antagonists.
De-Melo JD; Tonussi CR; D'Orléans-Juste P; Rae GA
Pain; 1998 Sep; 77(3):261-269. PubMed ID: 9808351
[TBL] [Abstract][Full Text] [Related]
5. Reversal of established responses to endothelin-1 in vivo and in vitro by the endothelin receptor antagonists, BQ-123 and PD 145065.
Warner TD; Allcock GH; Vane JR
Br J Pharmacol; 1994 May; 112(1):207-13. PubMed ID: 8032643
[TBL] [Abstract][Full Text] [Related]
6. Role and mechanism of endothelin-B receptors in mediating ET-1-induced vasoconstriction in pig skin.
Pang CY; Zhang J; Xu H; Lipa JE; Forrest CR; Neligan PC
Am J Physiol; 1998 Oct; 275(4):R1066-74. PubMed ID: 9756535
[TBL] [Abstract][Full Text] [Related]
7. ETA, mixed ETA/ETB receptor antagonists, and protein kinase C inhibitor prevent acute hypoxic pulmonary vasoconstriction: influence of potassium channels.
Goirand F; Bardou M; Guerard P; Dumas JP; Rochette L; Dumas M
J Cardiovasc Pharmacol; 2003 Jan; 41(1):117-25. PubMed ID: 12500029
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologic characterization of endothelin receptor responses in the isolated perfused rat lung.
Uhlig S; von Bethmann AN; Featherstone RL; Wendel A
Am J Respir Crit Care Med; 1995 Nov; 152(5 Pt 1):1449-60. PubMed ID: 7582276
[TBL] [Abstract][Full Text] [Related]
9. [Demonstration of a vasopressor role of endogenous endothelin after inhibition of nitric oxide synthesis in rats].
Richard V; Hogie M; Clozel M; Löffler BM; Thuillez C
Arch Mal Coeur Vaiss; 1995 Aug; 88(8):1213-6. PubMed ID: 8572876
[TBL] [Abstract][Full Text] [Related]
10. Bosentan antagonizes the effects of endothelin-1 on rat gastric blood flow and mucosal integrity.
Lazaratos S; Nakahara A; Goto K; Fukutomi H
Life Sci; 1995; 56(9):PL195-200. PubMed ID: 7869843
[TBL] [Abstract][Full Text] [Related]
11. Responses to endothelins in the rat cutaneous microvasculature: a modulatory role of locally-produced nitric oxide.
Lawrence E; Brain SD
Br J Pharmacol; 1992 Jul; 106(3):733-8. PubMed ID: 1504757
[TBL] [Abstract][Full Text] [Related]
12. The effect of bosentan, a new potent endothelin receptor antagonist, on the pathogenesis of cerebral vasospasm.
Shigeno T; Clozel M; Sakai S; Saito A; Goto K
Neurosurgery; 1995 Jul; 37(1):87-90; discussion 90-1. PubMed ID: 8587696
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of ETB receptors limits the efficacy of nonselective endothelin antagonists in vivo.
Allcock GH; Warner TD
J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S177-9. PubMed ID: 8587355
[TBL] [Abstract][Full Text] [Related]
14. Roles of endothelin receptors in the regional and systemic vascular responses to ET-1 in the anaesthetized ganglion-blocked rat: use of selective antagonists.
Allcock GH; Warner TD; Vane JR
Br J Pharmacol; 1995 Nov; 116(5):2482-6. PubMed ID: 8581288
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological characterization of cardiovascular responses induced by endothelin-1 in the perfused rat heart.
Kusumoto K; Fujiwara A; Ikeda S; Watanabe T; Fujino M
Eur J Pharmacol; 1996 Jan; 296(1):65-74. PubMed ID: 8720478
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of the mixed ET(A)/ET(B)-receptor antagonist bosentan on endothelin-induced bronchoconstriction, vasoconstriction and prostacyclin release.
Martin C; Held HD; Uhlig S
Naunyn Schmiedebergs Arch Pharmacol; 2000 Aug; 362(2):128-36. PubMed ID: 10961375
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II receptor blockade unmasks a depressor response to endothelin antagonists in rats.
Richard V; Hogie M; Thuillez C
Fundam Clin Pharmacol; 2000; 14(2):101-6. PubMed ID: 10796056
[TBL] [Abstract][Full Text] [Related]
18. Evidence from receptor antagonists of an important role for ETB receptor-mediated vasoconstrictor effects of endothelin-1 in the rat kidney.
Wellings RP; Corder R; Warner TD; Cristol JP; Thiemermann C; Vane JR
Br J Pharmacol; 1994 Feb; 111(2):515-20. PubMed ID: 8004396
[TBL] [Abstract][Full Text] [Related]
19. Effects of Ro 47-0203 and PD155080 on the plasma kinetics, receptor binding and vascular effects of endothelin in the pig.
Hemsén A; Modin A; Wanecek M; Malmström RE; Weitzberg E
Eur J Pharmacol; 1996 Dec; 318(2-3):369-76. PubMed ID: 9016927
[TBL] [Abstract][Full Text] [Related]
20. Effects of bosentan (Ro 47-0203), an ETA-, ETB-receptor antagonist, on regional haemodynamic responses to endothelins in conscious rats.
Gardiner SM; Kemp PA; March JE; Bennett T
Br J Pharmacol; 1994 Jul; 112(3):823-30. PubMed ID: 7921608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
